Sign in

CIK 0001359931

  • Non-accelerated filer
  • Smaller reporting company

Protara Therapeutics, Inc.

Sign in to watch
Ticker
TARA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
204580525
Phone
+1 646-844-0337
Business address
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
Former names
Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-08 Solomon Michael Edward Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2022-06-08 SARGEN GREGORY Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2022-06-08 GARCEAU ROGER Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2022-06-08 Smith Cynthia Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2022-06-08 BESHAR LUKE M Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2022-04-08 Opaleye Management Inc. 10% owner Purchase +5,322 $4.80 $26K 2,556,667
2022-04-08 Opaleye Management Inc. 10% owner Purchase +2,469 $4.80 $12K 127,500
2022-04-08 Opaleye Management Inc. 10% owner Purchase +5,322 $4.80 $26K 2,556,667
2022-04-08 Opaleye Management Inc. 10% owner Purchase +2,469 $4.80 $12K 127.5
2022-04-07 Opaleye Management Inc. 10% owner Purchase +1,345 $4.74 $6K 2,551,345
2022-04-07 Opaleye Management Inc. 10% owner Purchase +1,000 $4.74 $5K 125,031
2022-04-07 Opaleye Management Inc. 10% owner Purchase +1,345 $4.74 $6K 2,551,345
2022-04-07 Opaleye Management Inc. 10% owner Purchase +1,000 $4.74 $5K 125,031
2022-03-14 BESHAR LUKE M Director Purchase +10,000 $4.25 $43K 188,000
2022-03-10 BESHAR LUKE M Director Purchase +10,000 $4.46 $45K 178,000
2022-01-28 Opaleye Management Inc. 10% owner Purchase +20,000 $4.96 $99K 2,550,000
2022-01-28 Opaleye Management Inc. 10% owner Purchase +4,031 $4.96 $20K 124,031
2022-01-10 Zummo Jacqueline Chf Scientific Operations Off Shares withheld for taxes −4,603 $6.27 $29K 78,957
2022-01-10 Shefferman Jesse CEO and President Shares withheld for taxes −5,080 $6.27 $32K 872,425
2022-01-10 Bandari Jathin Chief Medical Officer Grant or award +13,500 13,500

Page 10 of 17 · 335 trades